[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533422":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":24,"locations":24,"responsibleParty":27,"collaborators":24,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":24,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":24,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":53,"whyStopped":24,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":24},{"fullName":5,"class":6},"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ghost ileostomy","EXPERIMENTAL","Laparoscopic or robotic surgery with ghost ileostomy",[13],"Procedure: Ghost ileostomy",{"label":15,"type":16,"description":17,"interventionNames":18},"No ileostomy","ACTIVE_COMPARATOR","Laparoscopic or robotic surgery with no ileostomy",[19],"Procedure: No ileostomy",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"PROCEDURE",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],{"type":28,"investigatorFullName":29,"investigatorTitle":30,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","fan li","Prof.","100533422","no-stoma-vs-ghost-stoma-in-patients-undergoing-total-mesorectal-excision-for-rectal-cancer-100533422",false,"NCT06225609","No Stoma VS Ghost Stoma in Patients Undergoing Total Mesorectal Excision for Rectal Cancer","Ghost Ileostomy Group Versus no Stoma Group in Patients Undergoing Total Mesorectal Excision for Rectal Cancer: A Randomized Controlled Study","Inclusion Criteria:\n\n* Pathologically confirmed rectal cancer.\n* age ≥18 years and ≤80 years.\n* intraoperative ghost ileostomy or no stoma was performed.\n\nExclusion Criteria:\n\n* ASA score \\>3.\n* Patients with coexisting complete intestinal obstruction.\n* History of long-term use of immunosuppressive drugs or glucocorticoids.\n* Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2.\n* Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure.\n* chronic renal failure (requiring dialysis or glomerular filtration rate \\\u003C30 mL\u002Fmin).\n\nIntraoperative combined multi-organ resection.\n\n* Combined cirrhosis of the liver.\n* Intraoperative findings of incomplete anastomosis and positive insufflation test.",true,"ALL","18 Years","80 Years",{"count":43,"type":44},500,"ESTIMATED","INTERVENTIONAL",[47],"NA","This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy group versus no ileostomy group after total mesorectal excision for rectal cancer.",[50],"Rectal Neoplasms",[9,15,52],"Rectal cancer","NOT_YET_RECRUITING","2024-01-17",{"date":56,"type":57},"2024-01-26","ACTUAL",{"date":59,"type":44},"2024-03-01",{"date":61,"type":44},"2027-03-01",{"name":29,"class":6}]